Inventor · disambiguated record
Monika Baehner
Also filed as: BAEHNER MONIKA
13 granted patents·14 pending applications·380 citations·filing 2003–2023
92Inventor score
Top patents by PatentIndex Score
27 records- 0197US8969526B2Antibody Fc variantsBAEHNER MONIKA·Filed 2012·Granted Mar 3, 2015·226 cites·8 claims
- 0297US8268314B2Bispecific anti-VEGF/anti-ANG-2 antibodiesBAEHNER MONIKA·Filed 2009·Granted Sep 18, 2012·70 cites·18 claims
- 0394US8945552B2Bispecific, bivalent anti-VEGF/anti-ANG-2 antibodiesBAEHNER MONIKA·Filed 2011·Granted Feb 3, 2015·36 cites·12 claims
- 0494US8703130B2Bispecific anti-VEGF/anti-ANG-2 antibodiesBAEHNER MONIKA·Filed 2012·Granted Apr 22, 2014·23 cites·12 claims
- 0592US9708396B2Bispecific anti-VEGF/anti-ANG-2 antibodiesHOFFMANN LA ROCHE·Filed 2014·Granted Jul 18, 2017·16 cites·17 claims
- 0684US2023399391A1Bispecific anti-vegf/anti-ang-2 antibodiesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0784US2024018259A1Antibody fc variantsROCHE GLYCART AG·Filed 2023·Application pending·0 cites
- 0883US9783570B2Method for separation of monomeric polypeptides from aggregated polypeptidesBAEHNER MONIKA·Filed 2012·Granted Oct 10, 2017·4 cites·3 claims
- 0980US8093006B2Antibodies against human tweak and uses thereofBAEHNER MONIKA·Filed 2010·Granted Jan 10, 2012·4 cites·10 claims
- 1072US2021047394A1Bispecific anti-vegf/anti-ang-2 antibodiesHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1169US2021139603A1Antibody fc variantsROCHE GLYCART AG·Filed 2020·Application pending·0 cites
- 1268US11168110B2Method for separation of monomeric polypeptides from aggregated polypeptidesHOFFMANN LA ROCHE·Filed 2020·Granted Nov 9, 2021·0 cites·14 claims
- 1361US10654886B2Method for separation of monomeric polypeptides from aggregated polypeptidesHOFFMANN LA ROCHE·Filed 2017·Granted May 19, 2020·0 cites·13 claims
- 1461US2017369566A1Bispecific anti-vegf/anti-ang-2 antibodiesHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 1560US9187550B2Tetranectin-apolipoprotein A-I, lipid particles containing it and its useBADER MARTIN·Filed 2011·Granted Nov 17, 2015·1 cites·19 claims
- 1659US2015191535A1Bispecific, bivalent anti-vegf/anti-ang2 antibodiesHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 1757US8883976B2Antibodies against human tweak and uses thereofBAEHNER MONIKA·Filed 2012·Granted Nov 11, 2014·0 cites·4 claims
- 1856US2017137530A1Antibody fc variantsROCHE GLYCART AG·Filed 2016·Application pending·0 cites
- 1955US8852887B2Antibodies against human tweak and uses thereofBAEHNER MONIKA·Filed 2011·Granted Oct 7, 2014·0 cites·16 claims
- 2052US2015239981A1Antibody fc variantsROCHE GLYCART AG·Filed 2015·Application pending·0 cites
- 2151US2017240626A1Bispecific, bivalent anti-vegf/anti-ang-2 antibodiesHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 2251US2005130260A1Refolded membrane protein in monodisperse formFiled 2003·Application pending·0 cites
- 2347US2015250725A1Method for producing a lipid particle, the lipid particle itself and its useHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 2446US9187564B2Antibodies against human TWEAK and uses thereofBAEHNER MONIKA·Filed 2011·Granted Nov 17, 2015·0 cites·11 claims
- 2544US2007031926A1Refolded membrane protein in monodisperse formLINDEN LARS·Filed 2006·Application pending·0 cites
- 2642US2009110686A1Antibodies against CCR5 and uses thereofAUER JOHANNES·Filed 2007·Application pending·0 cites
- 2742US2012190609A1Method for producing a lipid particle, the lipid particle itself and its useBADER MARTIN·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →